Inhibition of orotidine 5'-monophosphate decarboxylase and its therapeutic potential

Mini Rev Med Chem. 2008 Mar;8(3):239-47. doi: 10.2174/138955708783744065.

Abstract

Orotidine 5'-monophosphate decarboxylase (ODCase) is among the most proficient enzymes, and catalyzes the decarboxylation of OMP to UMP. An overview of ODCase and various proposals for its catalytic mechanism of decarboxylation are briefly presented here. A number of inhibitors of ODCase and new developments in the X-ray structures of ODCases from different species are discussed in the context of their therapeutic potential against cancer and infectious diseases. Latest discoveries in the inhibition of ODCase, for example using the novel C6 substitutions on the uridine, open new doors for drug discovery targeting parasitic diseases such as malaria.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Carboxylic Acids / chemistry
  • Carboxylic Acids / metabolism
  • Enzyme Inhibitors / pharmacology*
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Orotidine-5'-Phosphate Decarboxylase / antagonists & inhibitors*
  • Orotidine-5'-Phosphate Decarboxylase / metabolism
  • Uridine Monophosphate / biosynthesis
  • Uridine Monophosphate / chemistry

Substances

  • Carboxylic Acids
  • Enzyme Inhibitors
  • Uridine Monophosphate
  • Orotidine-5'-Phosphate Decarboxylase